Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Cipla
UBS
Mallinckrodt
Citi
Dow
Johnson and Johnson
Chinese Patent Office

Generated: July 18, 2018

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for Qudexy Xr

« Back to Dashboard

Bulk Pharmaceutical API Sources for Qudexy Xr

Vendor Vendor Homepage Vendor Sku API Url
Sigma-Aldrich ➤ Try a Free Trial T0575_SIGMA ➤ Try a Free Trial
NIH Clinical Collection ➤ Try a Free Trial SAM001246601 ➤ Try a Free Trial
Hangzhou Trylead Chemical Technology ➤ Try a Free Trial TL8006021 ➤ Try a Free Trial
NovoSeek ➤ Try a Free Trial 5284627 ➤ Try a Free Trial
Vendor Vendor Homepage Vendor Sku API Url

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Accenture
AstraZeneca
Fuji
McKinsey
Mallinckrodt
McKesson
Dow
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.